Evidence map›Paper›PMID 42782803›Full record

ReviewCells2026

E3 Ubiquitin Ligases in Neurodevelopmental Disorders.

Shuwan Wang, Xiang Pan, Kang Zhang, Deqiang Zhao, Xiaoxiao Chen, Yibei Wang, Haixia Hu, Yanfeng Zhang

Abstract readReview
In one paragraph

Review in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shuwan WangSchool of Exercise and Health, Shanghai University of Sport, Shanghai 200438, China.
Xiang PanChina Institute of Sport Science, Beijing 100061, China.
Kang ZhangSchool of Physical Education and Sports, Sichuan Normal University, Chengdu 610066, China.
Deqiang ZhaoChina Institute of Sport Science, Beijing 100061, China.ORCID 0009-0007-7123-2991
Xiaoxiao ChenSchool of Physical Education and Sports Rehabilitation, Jinzhou Medical University, Jinzhou 121001, China.
Yibei WangChina Institute of Sport Science, Beijing 100061, China.
Haixia HuAiyoudong Children and Youth Sports Health Research Institute, Weifang 261041, China.
Yanfeng ZhangSchool of Exercise and Health, Shanghai University of Sport, Shanghai 200438, China.

Funding

2024 Weifang Children and Adolescents Sports-Health Integration Innovation and Development Initiative B2422Scientific and Technological Countermeasures for Positive Health and Population Aging 2022YFC3600204
6 · The paper itself

Abstract

Neurodevelopmental disorders (NDDs) comprise a heterogeneous group of conditions that may present with developmental delay, intellectual disability, language impairment, epilepsy, autism-like features, motor abnormalities, or syndromic manifestations. Ubiquitination is an essential post-translational mechanism that regulates protein stability, localization, trafficking, and signaling. Because E3 ubiquitin ligases determine substrate specificity in this process, abnormalities in E3 ligases or E3-associated complexes can selectively affect proteins required for brain development and neuronal function. This review summarizes genetic and functional evidence linking E3 ubiquitin ligases, E3-complex components, substrate-recognition factors, and related ubiquitination regulators to NDDs. Gene Ontology enrichment analysis and mechanistic studies suggest that these genes converge on several major biological themes, including early neurodevelopment, neuronal migration, synaptic and circuit maturation, proteostasis, metabolism, and intracellular trafficking. However, the strength and translational relevance of the available evidence vary across genes.

Indexed as

Neurodevelopmental DisordersUbiquitin-Protein LigasesAnimalsHumansNeurodevelopmentUbiquitinationUbiquitin-Protein LigasesE3 ubiquitin ligasesneurodevelopmental disordersneurogenesisprotein homeostasissynaptic developmentubiquitination

Identifiers

PMID42782803
PMCPMC13605030

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.